Chevy Chase Trust Holdings LLC Sells 484 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Chevy Chase Trust Holdings LLC lessened its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 1.3% in the fourth quarter, HoldingsChannel.com reports. The fund owned 38,013 shares of the biotechnology company’s stock after selling 484 shares during the period. Chevy Chase Trust Holdings LLC’s holdings in Axon Enterprise were worth $22,592,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Geode Capital Management LLC lifted its stake in Axon Enterprise by 2.0% in the 3rd quarter. Geode Capital Management LLC now owns 1,782,828 shares of the biotechnology company’s stock valued at $710,103,000 after purchasing an additional 35,320 shares during the last quarter. Westfield Capital Management Co. LP lifted its stake in Axon Enterprise by 12.2% in the 3rd quarter. Westfield Capital Management Co. LP now owns 1,175,328 shares of the biotechnology company’s stock valued at $469,661,000 after purchasing an additional 127,769 shares during the last quarter. Champlain Investment Partners LLC lifted its stake in Axon Enterprise by 13.9% in the 3rd quarter. Champlain Investment Partners LLC now owns 682,420 shares of the biotechnology company’s stock valued at $272,695,000 after purchasing an additional 83,265 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Axon Enterprise by 1.6% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 561,263 shares of the biotechnology company’s stock valued at $224,281,000 after purchasing an additional 9,090 shares during the last quarter. Finally, Groupama Asset Managment bought a new position in Axon Enterprise in the 3rd quarter valued at approximately $200,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling

In related news, insider Jeffrey C. Kunins sold 2,304 shares of the stock in a transaction on Tuesday, December 3rd. The shares were sold at an average price of $654.79, for a total transaction of $1,508,636.16. Following the transaction, the insider now directly owns 128,542 shares of the company’s stock, valued at $84,168,016.18. This represents a 1.76 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the firm’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $604.07, for a total transaction of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares in the company, valued at $4,185,601.03. This trade represents a 6.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 8,711 shares of company stock valued at $5,631,561 over the last ninety days. 6.10% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the stock. Robert W. Baird increased their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Northland Securities upped their price target on shares of Axon Enterprise from $365.00 to $550.00 and gave the company an “outperform” rating in a research report on Monday, November 11th. JMP Securities upped their price target on shares of Axon Enterprise from $610.00 to $725.00 and gave the company a “market outperform” rating in a research report on Tuesday, February 4th. TD Cowen began coverage on shares of Axon Enterprise in a research report on Wednesday, January 8th. They issued a “buy” rating and a $700.00 price target for the company. Finally, Needham & Company LLC upped their price target on shares of Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. One analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $542.15.

Axon Enterprise Stock Up 2.8 %

Axon Enterprise stock opened at $683.41 on Friday. The company has a market capitalization of $52.11 billion, a PE ratio of 176.59, a PEG ratio of 6.79 and a beta of 1.05. Axon Enterprise, Inc. has a 12-month low of $260.27 and a 12-month high of $698.67. The firm’s fifty day moving average is $623.22 and its 200 day moving average is $507.71. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.